However, when we also adjusted for baseline levels of BMI, diabetes, and depression, higher levels IGF-1 and IGFBP-3 were still significantly related to a lower risk of frailty progression (Supplemental Tables 5 and 6). The gene discussed is IGF1; the disease is depressive symptom measurement.